Holen Sie sich die Stockscreener-App
4.46
0.45%
-0.02
Handel nachbörslich:
4.50
0.04
+0.90%
Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
95.07%
0.529
|
10.74 | 1.764 | 1.574 | 1.339 |
Operating Expenses
|
0.68%
9.188
|
9.251 | 27.46 | 15.51 | 22.78 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
0.68%
9.188
|
9.251 | 27.46 | 15.51 | 22.78 |
| Operating Income/Loss |
681.92%
-8.659
|
1.488 | -25.70 | -13.93 | -21.44 |
| Nonoperating Income/Loss |
11.40%
0.917
|
1.035 | 1.173 | 1.401 | 1.723 |
| Income/Loss From Continuing Operations Before Tax |
79.03%
0.529
|
2.523 | -24.53 | 1.574 | 1.339 |
| Income/Loss From Continuing Operations After Tax |
406.86%
-7.742
|
2.523 | -24.53 | -12.53 | -19.72 |
|
Net Income/Loss
|
406.86%
-7.742
|
2.523 | -24.53 | -12.53 | -19.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.12%
191.78
|
191.55 | 190.71 | 1.3641 | 189.00 |
| Diluted Average Shares |
0.32%
191.78
|
192.40 | 190.71 | -367.06 | 189.00 |
| Basic Earnings Per Share |
500.00%
-0.04
|
0.01 | -0.13 | -0.07 | -0.10 |
| Diluted Earnings Per Share |
500.00%
-0.04
|
0.01 | -0.13 | -0.07 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):